SOAs

18/02/2020

Statement of Advice (SOA): siltuximab (Sylvant) 1329

18/02/2020

Statement of Advice (SOA): sofosbuvir (Sovaldi) 3568

18/02/2020

Statement of Advice (SOA): silodosin (Silodyx) 461

18/02/2020

Statement of Advice (SOA): Dasatinib (Sprycel) 4067

18/02/2020

Statement of Advice (SOA): sildenafil (Revatio) 1051

18/02/2020

Statement of Advice (SOA): sevelamer carbonate (Renvela) 446

18/02/2020

Statement of Advice (SOA): sevelamer carbonate (Renvela) 3550

18/02/2020

Statement of Advice (SOA): dexamfetamine sulfate 2342

18/02/2020

Statement of Advice (SOA): doxorubicin (Caelyx) 114

18/02/2020

Statement of Advice (SOA): doxycycline (Adjusan) 2336

18/02/2020

Statement of Advice (SOA): saxagliptin (Onglyza) 2229

18/02/2020

Statement of Advice (SOA): eculizumab (Soliris) 2909

18/02/2020

Statement of Advice (SOA): eltrombopag (Revolade) 2595

18/02/2020

Statement of Advice (SOA): elvitegravir (Vitekta) 1061

18/02/2020

Statement of Advice (SOA): safinamide(Xadago) 2493

18/02/2020

Statement of Advice (SOA): rupatadine (Rupafin) 1755

18/02/2020

Statement of Advice (SOA): elvitegravir combination (Genvoya) 3628

18/02/2020

Statement of Advice (SOA): elvitegravir combination (Stribild) 3616

18/02/2020

Statement of Advice (SOA): epoetinalfa (Eprex) 3138

18/02/2020

Statement of Advice (SOA): epoetinzeta (Retacrit) 1226